A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
In the biggest overhaul in its 20-year history, the prestigious prize is replacing its 11-member grand jury with a 205-person ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results